Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 637295, 23 pages
http://dx.doi.org/10.1155/2014/637295
Review Article

The Membrane Associated RING-CH Proteins: A Family of E3 Ligases with Diverse Roles through the Cell

1Department of Immunology, University of Connecticut Health Center, L3056, Mc1319, 263 Farmington Avenue, Farmington, CT 06030, USA
2Department of Cellular and Molecular Physiology, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
3Department of Pathology, Yale School of Medicine, LH315B, 310 Cedar Street, New Haven, CT 06524, USA

Received 1 July 2014; Accepted 22 August 2014; Published 29 October 2014

Academic Editor: Jerome Moreaux

Copyright © 2014 Tasleem Samji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Boname and P. J. Lehner, “What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation?” Viruses, vol. 3, no. 2, pp. 118–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. E. Berndsen and C. Wolberger, “New insights into ubiquitin E3 ligase mechanism,” Nature Structural and Molecular Biology, vol. 21, no. 4, pp. 301–307, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Deshaies and C. A. P. Joazeiro, “RING domain E3 ubiquitin ligases,” Annual Review of Biochemistry, vol. 78, pp. 399–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Kerscher, R. Felberbaum, and M. Hochstrasser, “Modification of proteins by ubiquitin and ubiquitin-like proteins,” Annual Review of Cell and Developmental Biology, vol. 22, pp. 159–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Swanson, M. Locher, and M. Hochstrasser, “A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matα2 repressor degradation,” Genes and Development, vol. 15, no. 20, pp. 2660–2674, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Früh, E. Bartee, K. Gouveia, and M. Mansouri, “Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses,” Virus Research, vol. 88, no. 1-2, pp. 55–69, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. B. Dodd, M. D. Allen, S. E. Brown et al., “Solution structure of the Kaposi's sarcoma-associated herpesvirus K3 N-terminal domain reveals a novel E2-binding C4HC3-type RING domain,” Journal of Biological Chemistry, vol. 279, no. 51, pp. 53840–53847, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Boname and P. G. Stevenson, “MHC class I ubiquitination by a viral PHD/LAP finger protein,” Immunity, vol. 15, no. 4, pp. 627–636, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Haque, K. Ueda, K. Nakano et al., “Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8,” Journal of General Virology, vol. 82, no. 5, pp. 1175–1180, 2001. View at Google Scholar · View at Scopus
  10. L. Coscoy and D. Ganem, “Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 14, pp. 8051–8056, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Ishido, J.-K. Choi, B.-S. Lee et al., “Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein,” Immunity, vol. 13, no. 3, pp. 365–374, 2000. View at Google Scholar · View at Scopus
  12. J. A. Nathan and P. J. Lehner, “The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases,” Experimental Cell Research, vol. 315, no. 9, pp. 1593–1600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. W. Hewitt, L. Duncan, D. Mufti, J. Baker, P. G. Stevenson, and P. J. Lehner, “Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation,” The EMBO Journal, vol. 21, no. 10, pp. 2418–2429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Li, R. Means, S. Lang, and J. U. Jung, “Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5,” Journal of Virology, vol. 81, no. 5, pp. 2117–2127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Bartee, A. McCormack, and K. Früh, “Quantitative membrane proteomics reveals new cellular targets of viral immune modulators,” PLoS Pathogens, vol. 2, no. 10, article e107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Coscoy and D. Ganem, “A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation,” Journal of Clinical Investigation, vol. 107, no. 12, pp. 1599–1606, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Ishido, C. Wang, B.-S. Lee, G. B. Cohen, and J. U. Jung, “Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins,” Journal of Virology, vol. 74, no. 11, pp. 5300–5309, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mansouri, J. Douglas, P. P. Rose et al., “Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells,” Blood, vol. 108, no. 6, pp. 1932–1940, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Mansouri, K. Viswanathan, J. L. Douglas et al., “Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus,” Journal of Virology, vol. 83, no. 19, pp. 9672–9681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Sanchez, J. E. Gumperz, and D. Ganem, “Regulation of CD1d expression and function by a herpesvirus infection,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1369–1378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Karki, S. M. Lang, and R. E. Means, “The MARCH family E3 Ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation,” PLoS Pathogens, vol. 7, no. 4, Article ID e1001331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. M. Lang, M. O. F. Bynoe, R. Karki, M. A. Tartell, and R. E. Means, “Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins down regulate both DC-SIGN and DC-SIGNR,” PLoS ONE, vol. 8, no. 2, Article ID e58056, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Pardieu, R. Vigan, S. J. Wilson et al., “The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin,” PLoS Pathogens, vol. 6, no. 4, pp. 1–16, 2010. View at Google Scholar · View at Scopus
  24. K. Cadwell and L. Coscoy, “Biochemistry: ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase,” Science, vol. 309, no. 5731, pp. 127–130, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Cadwell and L. Coscoy, “The specificities of kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets,” Journal of Virology, vol. 82, no. 8, pp. 4184–4189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Wang, R. A. Herr, W.-J. Chua, L. Lybarger, E. J. H. J. Wiertz, and T. H. Hansen, “Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3,” Journal of Cell Biology, vol. 177, no. 4, pp. 613–624, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. L. M. Duncan, J. A. Nathan, and P. J. Lehner, “Stabilization of an E3 ligase-E2-ubiquitin complex increases cell surface MHC class I expression,” Journal of Immunology, vol. 184, no. 12, pp. 6978–6985, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. M. Duncan, S. Piper, R. B. Dodd et al., “Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules,” The EMBO Journal, vol. 25, no. 8, pp. 1635–1645, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Boname, M. Thomas, H. R. Stagg, P. Xu, J. Peng, and P. J. Lehner, “Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains,” Traffic, vol. 11, no. 2, pp. 210–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Goto, S. Ishido, Y. Sato et al., “c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity,” Journal of Biological Chemistry, vol. 278, no. 17, pp. 14657–14668, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Bartee, M. Mansouri, B. T. H. Nerenberg, K. Gouveia, and K. Früh, “Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins,” Journal of Virology, vol. 78, no. 3, pp. 1109–1120, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Morokuma, N. Nakamura, A. Kato et al., “MARCH-XI, a novel transmembrane ubiquitin ligase implicated in ubiquitin-dependent protein sorting in developing spermatids,” Journal of Biological Chemistry, vol. 282, no. 34, pp. 24806–24815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Holzerlandt, C. Orengo, P. Kellam, and M. Mar Albà, “Identification of new herpesvirus gene homologs in the human genome,” Genome Research, vol. 12, no. 11, pp. 1739–1748, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Ohmura-Hoshino, E. Goto, Y. Matsuki et al., “A novel family of membrane-bound E3 ubiquitin ligases,” Journal of Biochemistry, vol. 140, no. 2, pp. 147–154, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Fukuda, N. Nakamura, and S. Hirose, “MARCH-III is a novel component of endosomes with properties similar to those of MARCH-II,” Journal of Biochemistry, vol. 139, no. 1, pp. 137–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Nakamura, H. Fukuda, A. Kato, and S. Hirose, “MARCH-II is a syntaxin-6-binding protein involved in endosomal trafficking,” Molecular Biology of the Cell, vol. 16, no. 4, pp. 1696–1710, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Bartee, C. A. Eyster, K. Viswanathan, M. Mansouri, J. G. Donaldson, and K. Früh, “Membrane-associated RING-CH proteins associate with Bap31 and Target CD81 and CD44 to lysosomes,” PLoS ONE, vol. 5, no. 12, Article ID e15132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Yonashiro, S. Ishido, S. Kyo et al., “A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics,” The EMBO Journal, vol. 25, no. 15, pp. 3618–3626, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Nakamura, Y. Kimura, M. Tokuda, S. Honda, and S. Hirose, “MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology,” The EMBO Reports, vol. 7, no. 10, pp. 1019–1022, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. G. Kreft, L. Wang, and M. Hochstrasser, “Membrane topology of the yeast endoplasmic reticulum-localized ubiquitin ligase Doa10 and comparison with its human ortholog TEB4 (MARCH-VI),” Journal of Biological Chemistry, vol. 281, no. 8, pp. 4646–4653, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Hassink, M. Kikkert, S. Van Voorden et al., “TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum,” Biochemical Journal, vol. 388, no. 2, pp. 647–655, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Wang, R. A. Herr, and T. Hansen, “Viral and cellular MARCH ubiquitin ligases and cancer,” Seminars in Cancer Biology, vol. 18, no. 6, pp. 441–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Galbas, V. Steimle, R. Lapointe, S. Ishido, and J. Thibodeau, “MARCH1 down-regulation in IL-10-activated B cells increases MHC class II expression,” Cytokine, vol. 59, no. 1, pp. 27–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. A. de Gassart, V. Camosseto, J. Thibodeau et al., “MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 9, pp. 3491–3496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Thibodeau, M.-C. Bourgeois-Daigneault, G. Huppé et al., “Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes,” European Journal of Immunology, vol. 38, no. 5, pp. 1225–1230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. C. A. Eyster, N. B. Cole, S. Petersen, K. Viswanathan, K. Fruh, and J. G. Donaldson, “MARCH ubiquitin ligases alter the itinerary of clathrin-independent cargo from recycling to degradation,” Molecular Biology of the Cell, vol. 22, no. 17, pp. 3218–3230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Jahnke, J. Trowsdale, and A. P. Kelly, “Ubiquitination of HLA-DO by MARCH family E3 ligases,” European Journal of Immunology, vol. 43, no. 5, pp. 1153–1161, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Corcoran, M. Jabbour, C. Bhagwandin, M. J. Deymier, D. L. Theisen, and L. Lybarger, “Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1),” Journal of Biological Chemistry, vol. 286, no. 43, pp. 37168–37180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Jahnke, J. Trowsdale, and A. P. Kelly, “Ubiquitination of human leukocyte antigen (HLA)-DM by different membrane-associated RING-CH (MARCH) protein family E3 ligases targets different endocytic pathways,” Journal of Biological Chemistry, vol. 287, no. 10, pp. 7256–7264, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Matsuki, M. Ohmura-Hoshino, E. Goto et al., “Novel regulation of MHC class II function in B cells,” The EMBO Journal, vol. 26, no. 3, pp. 846–854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Ohmura-Hoshino, Y. Matsuki, M. Mito-Yoshida et al., “Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells,” Journal of Immunology, vol. 183, no. 11, pp. 6893–6897, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Walseng, K. Furuta, B. Bosch et al., “Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 47, pp. 20465–20470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Hunt, J. E. Wilson, K. A. Weih et al., “Francisella tularensis elicits IL-10 via a PGE2-inducible factor, to drive macrophage MARCH1 expression and class II down-regulation,” PLoS ONE, vol. 7, no. 5, Article ID e37330, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Li, J.-Y. Lu, Q. Liu, H.-W. Wang, and H. Guo, “Altered MARCH1 ubiquination-regulated dendritic cell immune functions during the early stage of zymosan-induced multiple organ dysfunction syndrome (MODS) in mice,” Immunology Letters, vol. 150, no. 1-2, pp. 105–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Oh, N. Wu, G. Baravalle et al., “MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells,” Journal of Experimental Medicine, vol. 210, no. 6, pp. 1069–1077, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. L. E. Tze, K. Horikawa, H. Domaschenz et al., “CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation,” Journal of Experimental Medicine, vol. 208, no. 1, pp. 149–165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. M.-C. Bourgeois-Daigneault, A. M. Pezeshki, T. Galbas et al., “Tollip-induced down-regulation of MARCH1,” Results in Immunology, vol. 3, pp. 17–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Jabbour, E. M. Campbell, H. Fares, and L. Lybarger, “Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression,” Journal of Immunology, vol. 183, no. 10, pp. 6500–6512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M.-C. Bourgeois-Daigneault and J. Thibodeau, “Identification of a novel motif that affects the conformation and activity of the MARCH1 E3 ubiquitin ligase,” Journal of Cell Science, vol. 126, no. 4, pp. 989–998, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. R. A. Herr, J. Harris, S. Fang, X. Wang, and T. H. Hansen, “Role of the RING-CH domain of viral ligase mK3 in ubiquitination of non-lysine and lysine MHC I residues,” Traffic, vol. 10, no. 9, pp. 1301–1317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M.-C. Bourgeois-Daigneault and J. Thibodeau, “Autoregulation of MARCH1 expression by dimerization and autoubiquitination,” Journal of Immunology, vol. 188, no. 10, pp. 4959–4970, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. D. R. Rhodes, J. Yu, K. Shanker et al., “ONCOMINE: a cancer microarray database and integrated data-mining platform,” Neoplasia, vol. 6, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. Z. Cao, A. Huett, P. Kuballa, C. Giallourakis, and R. J. Xavier, “DLG1 is an anchor for the E3 ligase MARCH2 at sites of cell-cell contact,” Cellular Signalling, vol. 20, no. 1, pp. 73–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. S.-O. Han, K. Xiao, J. Kim et al., “MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β2-adrenergic receptors,” Journal of Cell Biology, vol. 199, no. 5, pp. 817–830, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Walch, “Emerging role of the scaffolding protein Dlg1 in vesicle trafficking,” Traffic, vol. 14, no. 9, pp. 964–973, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Cheng and W. Guggino, “Ubiquitination and degradation of CFTR by the E3 ubiquitin ligase MARCH2 through its association with adaptor proteins CAL and STX6,” PLoS ONE, vol. 8, no. 6, Article ID e68001, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. T. J. Nice, W. Deng, L. Coscoy, and D. H. Raulet, “Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase,” Journal of Immunology, vol. 185, no. 9, pp. 5369–5376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. A. I. Su, M. P. Cooke, K. A. Ching et al., “Large-scale analysis of the human and mouse transcriptomes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 7, pp. 4465–4470, 2002. View at Google Scholar
  69. M. Karbowski, A. Neutzner, and R. J. Youle, “The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division,” Journal of Cell Biology, vol. 178, no. 1, pp. 71–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. A. Sugiura, S. Nagashima, T. Tokuyama et al., “MITOL regulates endoplasmic reticulum-mitochondria contacts via Mitofusin2,” Molecular Cell, vol. 51, no. 1, pp. 20–34, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. Y.-Y. Park, S. Lee, M. Karbowski, A. Neutzner, R. J. Youle, and H. Cho, “Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1,” Journal of Cell Science, vol. 123, no. 4, pp. 619–626, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. Y.-Y. Park and H. Cho, “Mitofusin 1 is degraded at G2/M phase through ubiquitylation by MARCH5,” Cell Division, vol. 7, article 25, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. R. Yonashiro, A. Sugiura, M. Miyachi et al., “Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation,” Molecular Biology of the Cell, vol. 20, no. 21, pp. 4524–4530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Sugiura, R. Yonashiro, T. Fukuda et al., “A mitochondrial ubiquitin ligase MITOL controls cell toxicity of polyglutamine-expanded protein,” Mitochondrion, vol. 11, no. 1, pp. 139–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Yonashiro, Y. Kimijima, T. Shimura et al., “Mitochondrial ubiquitin ligase MITOL blocks S-nitrosylated MAP1B-light chain 1-mediated mitochondrial dysfunction and neuronal cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 7, pp. 2382–2387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. H.-X. Shi, X. Liu, Q. Wang et al., “Mitochondrial ubiquitin ligase MARCH5 promotes TLR7 signaling by attenuating TANK action,” PLoS Pathogens, vol. 7, no. 5, Article ID e1002057, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Fang, C. Hemion, D. Goldblum et al., “Inactivation of MARCH5 prevents mitochondrial fragmentation and interferes with cell death in a neuronal cell model,” PLoS ONE, vol. 7, no. 12, Article ID e52637, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Fang, J. Li, J. Flammer, and A. Neutzner, “MARCH5 inactivation supports mitochondrial function during neurodegenerative stress,” Frontiers in Cellular Neuroscience, vol. 7, Article ID 176, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Nagase, K.-I. Ishikawa, N. Miyajima et al., “Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro,” DNA Research, vol. 5, no. 1, pp. 31–39, 1998. View at Publisher · View at Google Scholar · View at Scopus
  80. A. M. Zavacki, R. A. E Drigo, B. C. G. Freitas et al., “The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase,” Molecular and Cellular Biology, vol. 29, no. 19, pp. 5339–5347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. O. Foresti, A. Ruggiano, H. K. Hannibal-Bach, C. S. Ejsing, and P. Carvalho, “Sterol homeostasis requires regulated degradation of squalene monooxygenase by the ubiquitin ligase Doa10/Teb4,” eLife, vol. 2013, no. 2, Article ID e00953, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Wang, H. Dong, C. J. Soroka, N. W. Wei, J. L. Boyer, and M. Hochstrasser, “Degradation of the Bile salt export pump at endoplasmic reticulum in progressive familial Intrahepatic cholestasis type II,” Hepatology, vol. 48, no. 5, pp. 1558–1569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. J. A. Nathan, S. Sengupta, S. A. Wood et al., “The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X,” Traffic, vol. 9, no. 7, pp. 1130–1145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. P. J. Lehner, S. Hoer, R. B. Dodd, and L. M. Duncan, “Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases,” Immunological Reviews, vol. 207, pp. 112–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Ramalho-Santos, S. Yoon, Y. Matsuzaki, R. C. Mulligan, and D. A. Melton, “‘Stemness’: transcriptional profiling of embryonic and adult stem cells,” Science, vol. 298, no. 5593, pp. 597–600, 2002. View at Publisher · View at Google Scholar · View at Scopus
  86. S. M. Metcalfe, P. A. D. S. Muthukumarana, H. L. Thompson, M. A. Haendel, and G. E. Lyons, “Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance,” The FEBS Letters, vol. 579, no. 3, pp. 609–614, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. C. A. Szigyarto, P. Sibbons, G. Williams, M. Uhlen, and S. M. Metcalfe, “The E3 ligase axotrophin/MARCH-7: protein expression profiling of human tissues reveals links to adult stem cells,” Journal of Histochemistry and Cytochemistry, vol. 58, no. 4, pp. 301–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. B. Zhao, K. Ito, P. V. Iyengar, S. Hirose, and N. Nakamura, “MARCH7 E3 ubiquitin ligase is highly expressed in developing spermatids of rats and its possible involvement in head and tail formation,” Histochemistry and Cell Biology, vol. 139, no. 3, pp. 447–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. D. Flierman, C. S. Coleman, C. M. Pickart, T. A. Rapoport, and V. Chau, “E2-25K mediates US11-triggered retro-translocation of MHC class I heavy chains in a permeabilized cell system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 31, pp. 11589–11594, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. S. M. Metcalfe and P. A. D. S. Muthukumarana, “Transplantation tolerance: gene expression profiles comparing allotolerance vs. allorejection,” International Immunopharmacology, vol. 5, no. 1, pp. 33–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. P. A. D. S. Muthukumarana, G. E. Lyons, Y. Miura et al., “Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance,” International Immunopharmacology, vol. 6, no. 13-14, pp. 1993–2001, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. P. Muthukumarana, W.-J. Chae, S. Maher, B. R. Rosengard, A. L. M. Bothwell, and S. M. Metcalfe, “Regulatory transplantation tolerance and “stemness”: evidence that Foxp3 may play a regulatory role in SOCS-3 gene transcription,” Transplantation, vol. 84, supplement 1, no. 1, pp. S6–S11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. W. Gao, L. Thompson, Q. Zhou et al., “Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6,” Cell Cycle, vol. 8, no. 9, pp. 1444–1450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. N. Lapaque, M. Jahnke, J. Trowsdale, and A. P. Kelly, “The HLA-DRα chain is modified by polyubiquitination,” Journal of Biological Chemistry, vol. 284, no. 11, pp. 7007–7016, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Ohmura-Hoshino, Y. Matsuki, M. Aoki et al., “Inhibition of MHC class II expression and immune responses by c-MIR,” Journal of Immunology, vol. 177, no. 1, pp. 341–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Fujita, Y. Iwabu, K. Tokunaga, and Y. Tanaka, “Membrane-associated RING-CH (MARCH) 8 mediates the ubiquitination and lysosomal degradation of the transferrin receptor,” Journal of Cell Science, vol. 126, no. 13, pp. 2798–2809, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Jahnke, J. Trowsdale, and A. P. Kelly, “Structural requirements for recognition of major histocompatibility complex class II by membrane-associated RING-CH (MARCH) protein E3 ligases,” Journal of Biological Chemistry, vol. 287, no. 34, pp. 28779–28789, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. M.-É. Gauvreau, M.-H. Côté, M.-C. Bourgeois-Daigneault et al., “Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway,” Traffic, vol. 10, no. 10, pp. 1518–1527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Toyomoto, S. Ishido, N. Miyasaka, H. Sugimoto, and H. Kohsaka, “Anti-arthritic effect of E3 ubiquitin ligase, c-MIR, expression in the joints,” International Immunology, vol. 23, no. 3, pp. 177–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. R. Chen, M. Li, Y. Zhang, Q. Zhou, and H.-B. Shu, “The E3 ubiquitin ligase MARCH8 negatively regulates IL-1β-induced NF-κB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 35, pp. 14128–14133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. B. Van De Kooij, I. Verbrugge, E. De Vries et al., “Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1,” Journal of Biological Chemistry, vol. 288, no. 9, pp. 6617–6628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. L. Liu, N. M. M. Oliveira, K. M. Cheney et al., “A whole genome screen for HIV restriction factors,” Retrovirology, p. 94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. M. H. Kim, M. L. Rebbert, H. Ro, M. Won, and I. B. Dawid, “Cell adhesion in zebrafish embryos is modulated by March8,” PLoS ONE, vol. 9, no. 4, Article ID e94873, 2014. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Hoer, L. Smith, and P. J. Lehner, “MARCH-IX mediates ubiquitination and downregulation of ICAM-1,” The FEBS Letters, vol. 581, no. 1, pp. 45–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. D. J. Sanchez, L. Coscoy, and D. Ganem, “Functional organization of MIR2, a novel viral regulator of selective endocytosis,” Journal of Biological Chemistry, vol. 277, no. 8, pp. 6124–6130, 2002. View at Publisher · View at Google Scholar · View at Scopus
  106. S. Hör, T. Ziv, A. Admon, and P. J. Lehner, “Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase,” Molecular and Cellular Proteomics, vol. 8, no. 8, pp. 1959–1971, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. F. Deshaies, A. Brunet, D. A. Diallo, L. K. Denzin, A. Samaan, and J. Thibodeau, “A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 18, pp. 6443–6448, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. P. V. Iyengar, T. Hirota, S. Hirose, and N. Nakamura, “Membrane-associated RING-CH 10 (MARCH10 protein) is a microtubule- associated E3 ubiquitin ligase of the spermatid flagella,” Journal of Biological Chemistry, vol. 286, no. 45, pp. 39082–39090, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. K. Yogo, H. Tojima, J.-Y. Ohno et al., “Identification of SAMT family proteins as substrates of MARCH11 in mouse spermatids,” Histochemistry and Cell Biology, vol. 137, no. 1, pp. 53–65, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. A. Rebl, J. M. Köbis, U. Fischer et al., “MARCH5 gene is duplicated in rainbow trout, but only fish-specific gene copy is up-regulated after VHSV infection,” Fish and Shellfish Immunology, vol. 31, no. 6, pp. 1041–1050, 2011. View at Publisher · View at Google Scholar · View at Scopus